Observations of COVID-19 vaccine coverage and vaccine hesitancy on COVID-19 outbreak: An American ecological study

被引:1
作者
Bajracharya, Deewan [1 ]
Jansen, Rick J. [1 ,2 ]
机构
[1] North Dakota State Univ, Genom Phen & Bioinformat Program, Fargo, ND 58102 USA
[2] Univ Minnesota, Masonic Canc Ctr, Biostat Core, Minneapolis, MN USA
基金
美国国家卫生研究院;
关键词
COVID-19; SARS-CoV-2; Vaccination coverage; Vaccine hesitancy; cases; Deaths; Hospitalizations;
D O I
10.1016/j.vaccine.2023.12.008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In this ecological study, we aim to establish the role vaccines play in bringing the pandemic under control, as well as the impact of pathogen variants, vaccine hesitancy, and medical resource availability during the process by utilizing publicly available data. The study spans a three-year data collection period for daily hospital admissions due to COVID-19 and the daily reported cases of COVID-19 across all 50 states in the USA. In doing so, we aim to demonstrate the difference in severity of the SARS-CoV-2 pathogen among vaccinated and unvaccinated populations in the USA. The study assesses the correlation of COVID-19 vaccines (e.g., Pfizer, Moderna, and Janssen) and disease outcomes (transmissibility, severity, and deaths) caused by different strains of SARSCoV-2 and establishes a negative correlation between COVID-19 vaccine and disease outcomes. By considering potential confounders in vaccine hesitancy, medical resource availability and vaccine dosage, we demonstrate the aforementioned to be insubstantial in predicting disease outcomes while the latter displays a contrasting significance in terms of disease outcomes. Between all the major variants of concern, the Delta and Omicron variants in particular have been associated with higher virulence and transmissibility factors respectively. Hence, the CDC continues to encourage the US population to get vaccinated since vaccines are one of the most effective ways to protect the community from potential outbreaks and prevent severe disease manifestations.
引用
收藏
页码:246 / 254
页数:9
相关论文
共 43 条
  • [1] Abedi V, 2021, J RACIAL ETHN HEALTH, V8, P732, DOI [10.1007/s40615-020-00833-4, 10.1101/2020.04.26.20079756]
  • [2] Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins
    Anand, Sai Priya
    Chen, Yaozong
    Prevost, Jeremie
    Gasser, Romain
    Beaudoin-Bussieres, Guillaume
    Abrams, Cameron F.
    Pazgier, Marzena
    Finzi, Andres
    [J]. VIRUSES-BASEL, 2020, 12 (10):
  • [3] Andrews N, 2022, NEW ENGL J MED, V386, P1532, DOI [10.1016/S1473-3099(22)00309-7, 10.1056/NEJMoa2119451]
  • [4] The hidden vulnerability of homelessness in the COVID-19 pandemic: Perspectives from India
    Banerjee, Debanjan
    Bhattacharya, Prama
    [J]. INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY, 2021, 67 (01) : 3 - 6
  • [5] Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
    Barda, Noam
    Dagan, Noa
    Ben-Shlomo, Yatir
    Kepten, Eldad
    Waxman, Jacob
    Ohana, Reut
    Hernan, Miguel A.
    Lipsitch, Marc
    Kohane, Isaac
    Netzer, Doron
    Reis, Ben Y.
    Balicer, Ran D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (12) : 1078 - 1090
  • [6] Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
    Bernal, Jamie Lopez
    Andrews, Nick
    Gower, Charlotte
    Gallagher, Eileen
    Simmons, Ruth
    Thelwall, Simon
    Stowe, Julia
    Tessier, Elise
    Groves, Natalie
    Dabrera, Gavin
    Myers, Richard
    Campbell, Colin N. J.
    Amirthalingam, Gayatri
    Edmunds, Matt
    Zambon, Maria
    Brown, Kevin E.
    Hopkins, Susan
    Chand, Meera
    Ramsay, Mary
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (07) : 585 - 594
  • [7] Impact of the Delta variant on vaccine efficacy and response strategies
    Bian, Lianlian
    Gao, Qiushuang
    Gao, Fan
    Wang, Qian
    He, Qian
    Wu, Xing
    Mao, Qunying
    Xu, Miao
    Liang, Zhenglun
    [J]. EXPERT REVIEW OF VACCINES, 2021, 20 (10) : 1201 - 1209
  • [8] CDC, SARS-coV-2 variant classifications and definitions
  • [9] CDC, CDC COVID Data Tracker
  • [10] CDC, OV TEST SARS COV 2 V